Intervention not reported
Haematological adverse events (grade 3 or 4) · patients with early‐stage cervical cancer (FIGO stages IB1, IB2 or IIA)
The intervention showed no clear difference in haematological adverse events (grade 3 or 4) (moderate certainty).
1 finding from 1 review
- Radiotherapy and chemoradiation after surgery for early cervical cancer 2012 · Cochrane Headline outcomes onlyRR 2.38 [0.63, 9.05]2 studies · 388 participantsModerate